Tom Garner Joins Lexicon as Senior Vice President and Chief Commercial Officer
THE WOODLANDS, Texas, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Tom Garner is joining the company as senior vice president and chief commercial officer, effective October 9, 2023.
- THE WOODLANDS, Texas, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Tom Garner is joining the company as senior vice president and chief commercial officer, effective October 9, 2023.
- During his time at BMS, Mr. Garner held a broad array of roles throughout BMS’ commercial organization including positions at local, country, and global levels, and across a diverse range of brands and therapeutic areas.
- In his most recent role, Mr. Garner was the senior vice president and head of the U.S. Cardiovascular and Established Brands business unit, the single largest business unit across the BMS enterprise with reported total revenues in excess of $10 billion.
- “We are very excited that Mr. Garner is joining Lexicon as our chief commercial officer,” said Lonnel Coats, Lexicon’s chief executive officer.